Page last updated: 2024-08-24

topotecan and Pyrexia

topotecan has been researched along with Pyrexia in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (25.00)	18.2507
2000's	2 (50.00)	29.6817
2010's	1 (25.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Amrahli, M; Centelles, MN; Gedroyc, W; Miller, AD; So, PW; Stebbing, J; Thanou, M; Wright, M; Xu, XY	1
Goldwasser, F; Gross-Goupil, M; Hasbini, A; Lokiec, F; Lopez, G; Misset, JL; Romain, D; Tigaud, JM	1
Cui, BX; Jiang, J; Kong, BH; Meng, LH; Su, SL; Wang, B; Wang, LJ; Yang, XS; Zhang, YZ	1
Abbruzzese, JL; al-Bitar, M; Andreeff, M; Arbuck, S; Beran, M; Estey, E; Kantarjian, H; Keating, M; Koller, C; Moore, M; O'Brien, S; Pierce, S	1

Trials

3 trial(s) available for topotecan and Pyrexia

Article	Year
Topotecan preceded by oxaliplatin using a 3 week schedule: a phase I study in advanced cancer patients. European journal of cancer (Oxford, England : 1990), 2002, Volume: 38, Issue:14 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Diarrhea; Drug Synergism; Female; Fever; Humans; Infections; Male; Middle Aged; Neoplasms; Nervous System Diseases; Neutropenia; Organoplatinum Compounds; Ovarian Neoplasms; Oxaliplatin; Patient Dropouts; Thrombocytopenia; Topotecan; Treatment Outcome	2002
[Clinical study of topotecan and cisplatin as first line chemotherapy in epithelial ovarian cancer]. Zhonghua fu chan ke za zhi, 2007, Volume: 42, Issue:10 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Cyclophosphamide; Cystadenocarcinoma, Serous; Disease-Free Survival; Drug Administration Schedule; Female; Fever; Follow-Up Studies; Humans; Leukopenia; Middle Aged; Neoplasm Staging; Neutropenia; Ovarian Neoplasms; Paclitaxel; Prognosis; Survival Rate; Topotecan; Treatment Outcome	2007
Topotecan, a topoisomerase I inhibitor, is active in the treatment of myelodysplastic syndrome and chronic myelomonocytic leukemia. Blood, 1996, Oct-01, Volume: 88, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Camptothecin; Diarrhea; Female; Fever; Follow-Up Studies; Genes, ras; Humans; Leukemia, Myelomonocytic, Chronic; Life Tables; Male; Middle Aged; Myelodysplastic Syndromes; Neoplasm Proteins; Remission Induction; Stomatitis; Survival Analysis; Survival Rate; Topoisomerase I Inhibitors; Topotecan; Treatment Outcome	1996

Other Studies

1 other study(ies) available for topotecan and Pyrexia

Article	Year
Image-guided thermosensitive liposomes for focused ultrasound drug delivery: Using NIRF-labelled lipids and topotecan to visualise the effects of hyperthermia in tumours. Journal of controlled release : official journal of the Controlled Release Society, 2018, 06-28, Volume: 280 Topics: Animals; Antineoplastic Agents; Coordination Complexes; Drug Delivery Systems; Drug Liberation; Fever; Gadolinium; High-Intensity Focused Ultrasound Ablation; Humans; Hyperthermia, Induced; Indicators and Reagents; Lipids; Liposomes; Magnetic Resonance Imaging; Mice, Inbred BALB C; Neoplasms; Optical Imaging; Temperature; Tissue Distribution; Topotecan; Tumor Microenvironment	2018

Article

Year

Image-guided thermosensitive liposomes for focused ultrasound drug delivery: Using NIRF-labelled lipids and topotecan to visualise the effects of hyperthermia in tumours.

Journal of controlled release : official journal of the Controlled Release Society, 2018, 06-28, Volume: 280

Topics: Animals; Antineoplastic Agents; Coordination Complexes; Drug Delivery Systems; Drug Liberation; Fever; Gadolinium; High-Intensity Focused Ultrasound Ablation; Humans; Hyperthermia, Induced; Indicators and Reagents; Lipids; Liposomes; Magnetic Resonance Imaging; Mice, Inbred BALB C; Neoplasms; Optical Imaging; Temperature; Tissue Distribution; Topotecan; Tumor Microenvironment

2018